We’re closer than ever to ending the HIV epidemic.
Bridge HIV at the San Francisco Department of Public Health is now enrolling for a phase 1 HIV antibody infusion study.
The main purpose of phase 1 studies is to test the safety of the product, and to see if it causes an immune response.
Participation in a phase 1 study are specific to each study but might include:
• Giving urine, blood, and/or other samples.
• Receiving an investigational vaccine or antibody infusion.
• Visits to our clinic for 1-2 years.
• Keeping a diary for several days after injection or infusion visits.
• Regular contact with study clinicians.
• Regular physical exams.
• Answering questionnaires.
You may be eligible if you are:
• Between 18-65 years old, HIV negative, and in general good health.
• People who are taking PrEP may also be eligible for these studies.
Eligible participants will receive up to $175 per visit for their time and travel.